Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 3, Number 3—September 1997

Perspective

Resistance, Remission, and Qualitative Differences in HIV Chemotherapy

Denise E. Kirschner*Comments to Author  and G.F. Webb
Author affiliations: *University of Michigan Medical School, Ann Arbor, Michigan, USA; and †Vanderbilt University, Nashville, Tennessee, USA

Main Article

Figure 3

Treatment simulations for four starting viral levels. The simulations have a common viral set-point of disease progression, and the treatment starting values are from Figure 1a,b. For all four simulations, the treatment parameters are c1=2.0, c2=1.0, c3=.1, the resistance mutation parameter is q=10-7, and the threshold value is V0=.5 (indicated by the horizontal line). The lowest starting viral level achieves remission (a), while the other three develop resistance.

Figure 3. Treatment simulations for four starting viral levels. The simulations have a common viral set-point of disease progression, and the treatment starting values are from Figure 1a,b. For all four simulations, the treatment parameters are c1=2.0, c2=1.0, c3=.1, the resistance mutation parameter is q=10-7, and the threshold value is V0=.5 (indicated by the horizontal line). The lowest starting viral level achieves remission (a), while the other three develop resistance.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO